. 2015 Feb 20;8(2):e20039. doi: 10.5812/jjm.20039

Table 2. Comparison of the Demographic Features and the Leukocyte, CRP, MPW and RDW Levels of the Subjects in the Control Group During Brucellosis Treatment and in the First-Year Follow-Up ^{a, b}.

	Control Group (n = 101)	Control Group in the First Year Follow - Up (n = 88)	P Value
Age, y	48.89 ± 7.07	49.45 ± 12.68	> 0.05 (0.113)
Male/Female	50/51 (1.50 ± 0.50)	39/49 (1.51 ± 0.45)	> 0.05 (0.530)
Leukocyte, × 10 ³ /mm ³	7.4 ± 2.0	7.1 ± 2.0	> 0.05 (0.150)
CRP, mg/L	4.81 ± 4.89	5.44 ± 8.91	> 0.05 (0.678)
MPV, fL	7.67 ± 1.29	7.65 ± 1.54	> 0.05 (0.940)
RDW, %	15.90 ± 1.45	16.10 ± 1.79	> 0.05 (0.326)

^a Abbreviations: CRP: C-Reactive Protein, MPV: Mean Platelet Volume, RDW: Red Blood Cell Distribution.

^b Data are presented as Mean ± SD.

Table 2. Comparison of the Demographic Features and the Leukocyte, CRP, MPW and RDW Levels of the Subjects in the Control Group During Brucellosis Treatment and in the First-Year Follow-Up a, b.